Lecture: Changing the trajectory of heart failure - To help your patients endure

12 Nov 2020

Opening & discussion


Heart failure - Current status in Hong Kong


Changing the course of heart failure


Hospitalisation and mortality in patients with heart failure treated with sacubitril/valsartan vs. enalapril - What does the real-world evidence show us?


This is an educational material to HCPs sponsored by Novartis Pharmaceuticals (HK) Ltd, for the purpose of continuing medical education only.